E-cig conférence 2022

Programme

DAY 1 – 5 December, 2022

8:30 > 9:00 a.m

Welcome participants / Coffee

9:00 > 9:30 a.m

OPENING SESSION

9:30 > 10:15 a.m

KEYNOTE PRESENTATION

E-Cigarettes: Key Policy and Research Questions
> Mitch Zeller, J.D, Retired Director, U.S. Food and Drug Administration, Center for Tobacco Products

10:15 > 11:30a.m

PLENARY SESSION
E-Cigarette research challenges

Chair: Karl Erik Lund, Norwegian Institute of Public Health 
Jamie Hartmann-Boyce, University of Oxford
>
Paraskevi Katsaounou, Medical School of the National and Kapodistrian University of Athens 
Ute Mons, University of Cologne and the German Cancer Research Center (DKFZ)
> Caitlin Notley, University of East Anglia
> Lion Shahab, University College London

11:30 > 11:45 a.m

Coffee break

11:45 > 12:45 a.m

PARALLEL SESSION N°1

SYMPOSIUM 1

Chair: Martin Dockrell

Effect of Electronic Cigarettes on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial
> Jonathan Foulds

Association of Electronic Cigarette Use With Discontinuation of Cigarette Smoking Among Adult Smokers Who Were Initially Never Planning to Quit
> Karin Kasza

Do the associations between the use of electronic cigarettes and smoking reduction or cessation attempt persist after several years of use? Longitudinal analyses in smokers of the CONSTANCES cohort
> Guillaume Airagnes

SYMPOSIUM 2

Chair: Jérémie Achille

Regulation of electronic cigarettes and novel tobacco products in EU Member States
> Olga Caratier

To evaluate the use, abuse potential and health risks of novel tobacco products and e-cigarettes
> Jérémie Achille

Investigations regarding e-cigarettes and novel tobacco products awareness, use and perceptions
> Silvano Gallus

WORKSHOP 1

Chair: Jérémie Pourchez 

Correlates of perceived addiction and product addictiveness of e-cigarettes – the EValuation of the Addictive Potential of E-cigarettes (EVAPE) project
> Valérie Lohner

Self-reported signs of Substance Use Disorder in e-cigarette online forums
> Marike Andreas

Sensory appeal and puffing intensity of e-cigarette use: influence of nicotine salts versus free-base nicotine in e-liquids
> Charlotte Pauwels

Youth’s views and experimentation with disposable e-cigarettes: using focus groups
> Marissa Smith

 

12:45 > 2:00 p.m

Lunch

POSTER SESSION 1 

12:50-1:10: Marketing and young people
Chair : Florence Cousson-Gélie, University of Montpellier

1:00-1:30:
Smokers, vapers, dual users
Chair : Christophe Tzourio, University of Bordeaux

2:00 > 2:45 p.m

KEYNOTE PRESENTATION

E-cigarette and tobacco use: friend or foe?
> Maria Melchior,
French National Institute of Health and Medical Research (INSERM)

2:45 > 4:00 p.m

PARALLEL SESSION N°2

WORKSHOP 2

Chair: Paraskevi Katsaounou

Health Effects of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
> David T. Levy

Electronic Nicotine Delivery Systems (ENDS) use during a five-year period is not associated with self-reported chronic obstructive pulmonary disease (COPD) after adjustment of cigarette smoking history: A longitudinal analysis of PATH data.
> Rafael Meza

Unintended consequences of vaping: injuries from poisonings and explosions
> Debbie Robson

WORKSHOP 3

Chair: Véronique Régnier

European adult smokers’ perceptions of the harmfulness of e-cigarettes relative to combustible cigarettes: Findings from the France and EUREST-PLUS ITC Surveys
> Geoffrey Fong

An appeal that does not last: French youths’ attitude toward e-cigarette. Results from the ARAMIS study (2014, 2019)
> Marc-Antoine Douchet

Electronic cigarette packaging in context: an exploratory study
> Frances Thirlway

WORKSHOP 4

Chair: Caitlin Notley

Using ecological momentary assessment via text messaging to measure cigarette and e-cigarette use patterns
> Elizabeth Stevens

Tracking via Repeated Assessment of Joint E-Cigarette and Tobacco use (TRAJECT): Descriptive and qualitative findings exploring trajectories of dual e-cigarette and tobacco use
> Emma Ward

Adolescents (15-18 years old) in the narratives of experimentation/use trajectories: structuring factors and their effects on transitions between vaping and smoking
> Lara Leclerc

The impact of electronic cigarette and heated tobacco product on conventional smoking: an Italian prospective cohort study form Italy conducted during the COVID-19 pandemic
> Silvano Gallus

4:00 > 4:15 p.m

Coffee break

4:15 > 5:00 p.m

KEYNOTE PRESENTATION

Flavours and flavourings in e-cigarettes: prevalence, perception and regulation
> Reinskje Talhout, National Institute for Public Health and the Environment (RIVM)

5:00 > 5:45 p.m

PLENARY SESSION
Lessons from workshops

Chair: Marcus Munafo, University of Bristol
Jamie Hartmann-Boyce, University of Oxford
>
Paraskevi Katsaounou, Medical School of the National and Kapodistrian University of Athens
Caitlin Notley, University of East Anglia
Jérémie Pourchez, Ecole Nationale Supérieure des mines
Veronique Régnier, University of Saint-Etienne

6:00 > 7:00 p.m

Cocktail

DAY 2 – 6 December, 2022

8:45 > 9:15 a.m

Welcome participants / Coffee

9:15 > 10:00 a.m

KEYNOTE PRESENTATION

Vaping and the vulnerable
> Ann McNeill, King’s College London

10:00 > 10:45 a.m

KEYNOTE PRESENTATION

The ITC Nicotine Product Conceptual Model: A Framework for Understanding Transitions Among
Cigarettes, E-Cigarettes, and Other Nicotine Products and the Impact of Policies on Those Transitions

> Geoffrey Fong,
University of Waterloo

10:45 > 11:30 a.m

Coffee break

POSTER SESSION 2

Trajectory and prevalence: around the world
Chair: Silvano Gallus, Mario Negri Institute

11:30 > 12:45 p.m

PARALLEL SESSION N°3

WORKSHOP 5

Chair : Reinskje Talhout

Comparison of chemical composition and toxicity effects of emissions from electronic cigarettes, heated tobacco products and tobacco cigarettes in human bronchial epithelial cells
> Gianni Zarcone

Chemical Profiles and Toxicity of Electronic Cigarettes: An Umbrella Review
> David T. Levy 
> Nargiz Travis

Metabolomic strategy to identify markers of exposure and toxicity of electronic cigarettes, heated tobacco products and tobacco cigarettes,
> Marie Lenski 

WORKSHOP 6

Chair: Lion Shahab

An online randomised optimisation experiment to identify effective intervention components to support smokers to use e-cigarettes in a quit attempt
> Lynne Dawkins

Effect of Tobacco Cessation Aids on Smoking Cessation and Duration of Abstinence: a French Population-Based Study
> Mathilde Fekom

E-cigarettes for smoking cessation: the latest Cochrane living systematic review evidence
> Ailsa Butler & Jamie Hartmann-Boyce

Use of pod device e-cigarettes in the Cessation of Smoking Trial in the Emergency Department
> Ian Pope

SYMPOSIUM 3

Chairs: François Alla and Ivan Berlin

Are ENDS an aid to quit smoking and what can be its role in a global smoking cessation strategy? Can these products be considered as risk reduction tools?
> Ivan Berlin

Recommendations of the French High Council of Public Health, France (HCPH) on the benefit/risk profile of electronic cigarettes among specific groups of smokers
> Anne-Laurence Le Faou

Is there a risk that ENDS encourage a renormalization of tobacco consumption in France?
> Karine Gallopel-Morvan

Is ENDS use a gateway for becoming a smoker among youths?
> François Alla

12:45 > 2:15 p.m

Lunch

POSTER SESSION 3 

12:45-1:45 : Addictiveness and toxicity
Chair: Benoît Labarbe, French Agency for Food, Environmental and Occupational Health & Safety (ANSES)

1:30-2:10: Smoking cessation:what interventions?
Chair: Anne-Fleur Guillemin, French National Cancer Institute

2:15 > 3:30 p.m

PARALLEL SESSION N°4

WORKSHOP 7

Chair: Ute Mons

Prevalence of vaping in France in 2021: results from the Santé publique France Health Barometer
> Anne Pasquereau

E-cigarette Use and its Associated Factors Among a Sample of Romanian Pregnant Smokers and Ex-smokers
> Rana Jaber

Tobacco and e-cigarette use among French adolescents. Prevalence, trends and associations: where we are in 2022?
> Eric Janssen

Birth-cohort patterns of e-cigarette use among adolescents in the US
> Rafael Meza

SYMPOSIUM 4

Chair: Ann McNeill

Methods and health risks of nicotine and flavourings
> Debbie Robson

Biomarkers of exposure
> Eve Taylor

Cancer, respiratory and cardiovascular diseases (CVD)
> Leonie Brose

Overview of methodological limitations when assessing vaping effects on health biomarkers
> Erikas Simonavičius

3:30 > 3:45 p.m

Coffee break

3:45 > 4:30 p.m

KEYNOTE PRESENTATION

From Lab Bench to Population Impact: Investigating Health Effects of E-cigarettes
> Maciej Goniewicz,
Department of Health Behavior Roswell Park Comprehensive Cancer Center

4:30 > 5:15 p.m

PLENARY SESSION
Lessons from workshops

Co-chairs: Anbu Paramasivam, Cancer Research UK & Martin Dockrell, Office for Health Improvement and Disparities
Ute Mons, University of Cologne and the German Cancer Research Center (DKFZ)
> Lion Shahab, University College London
Reinskje Talhout, National Institute for Public Health and the Environment (RIVM)

5:15 > 5:45 p.m

Closing ceremony

Click to listen highlighted text!